Federation Bio, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2019-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.federation.bio
Safety and Tolerability of FB-001 in Healthy Adult Volunteers and Adult Subjects With Enteric Hyperoxaluria
Phase 1
Recruiting
- Conditions
- Enteric HyperoxaluriaHealthy
- Interventions
- Biological: FB-001Biological: Placebo
- First Posted Date
- 2022-12-14
- Last Posted Date
- 2023-01-25
- Lead Sponsor
- Federation Bio Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT05650112
- Locations
- 🇺🇸
Medpace Clinical Pharmacology Unit, Cincinnati, Ohio, United States
© Copyright 2025. All Rights Reserved by MedPath